Donald Little III

Dr. Donald Little III is a researcher in the Biology department at Concordia University Ann Arbor, specializing in adrenal physiology, cancer biology, and endocrinology. His work bridges molecular biology, epigenetic regulation, and disease mechanisms.

Education:

• Ph.D. in Cancer Biology, University of Michigan (2021)
• B.S. in Genetics with minor in Wildlife Science, Purdue University (2015)

Research focuses include:

• Wnt signaling in adrenal development
• Epigenetic mechanisms in adrenocortical carcinoma
• Impact of race/gender on cancer prognosis
• Hormonal regulation and zonation disorders

Publications span journals like Molecular and Cellular Endocrinology, Cancer Research, and PLOS One, with recurring themes in signaling pathways, chromatin dynamics, and disease pathology.

Awards:

• Outstanding Abstract Award (ENDO 2022, 2021, 2020)
• Presidential Poster Presentation (ENDO 2020)
• 3rd Place - Cancer Biology Program Retreat (2016)

Active in academic governance as Co-Chair of the Faculty Summit Committee and IRB member. Professional memberships include National Audubon Society and former Endocrine Society/AAAS affiliations.